Roche Holding AG (RHHBY)
50.42
+0.19
(+0.38%)
USD |
OTCM |
Jun 10, 16:00
Roche Market Cap
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| May 27, 2026 | 334.26B |
| May 26, 2026 | 335.09B |
| May 22, 2026 | 339.80B |
| May 21, 2026 | 335.79B |
| May 20, 2026 | 330.89B |
| May 19, 2026 | 330.38B |
| May 18, 2026 | 325.53B |
| May 15, 2026 | 325.47B |
| May 14, 2026 | 326.74B |
| May 13, 2026 | 326.55B |
| May 12, 2026 | 326.04B |
| May 11, 2026 | 327.51B |
| May 08, 2026 | 325.47B |
| May 07, 2026 | 322.25B |
| May 06, 2026 | 328.91B |
| May 05, 2026 | 323.88B |
| May 04, 2026 | 320.31B |
| May 01, 2026 | 324.90B |
| April 30, 2026 | 324.13B |
| April 29, 2026 | 321.27B |
| April 28, 2026 | 325.15B |
| April 27, 2026 | 326.30B |
| April 24, 2026 | 328.97B |
| April 23, 2026 | 330.38B |
| April 22, 2026 | 326.17B |
| Date | Value |
|---|---|
| April 21, 2026 | 318.08B |
| April 20, 2026 | 327.00B |
| April 17, 2026 | 326.62B |
| April 16, 2026 | 318.08B |
| April 15, 2026 | 324.83B |
| April 14, 2026 | 325.09B |
| April 13, 2026 | 322.92B |
| April 10, 2026 | 318.78B |
| April 09, 2026 | 320.50B |
| April 08, 2026 | 319.04B |
| April 07, 2026 | 314.39B |
| April 06, 2026 | 318.40B |
| April 02, 2026 | 317.57B |
| April 01, 2026 | 321.08B |
| March 31, 2026 | 316.68B |
| March 30, 2026 | 311.14B |
| March 27, 2026 | 307.76B |
| March 26, 2026 | 310.37B |
| March 25, 2026 | 311.84B |
| March 24, 2026 | 305.98B |
| March 23, 2026 | 306.49B |
| March 20, 2026 | 301.87B |
| March 19, 2026 | 308.40B |
| March 18, 2026 | 313.56B |
| March 17, 2026 | 324.77B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novartis AG | 294.23B |
| Eli Lilly & Co. | 1.098T |
| Pfizer Inc. | 149.60B |
| GSK Plc | 106.51B |
| Johnson & Johnson | 576.21B |
Market Cap Related Metrics
| PE Ratio | 20.99 |
| PS Ratio | 4.370 |
| PEG Ratio | 0.99 |
| Price to Free Cash Flow | 21.50 |
| Price | 50.42 |
| Earnings Yield | 4.77% |
| PEGY Ratio | 0.8647 |
| Operating PE Ratio | 14.22 |
| Normalized PE Ratio | 17.99 |